University of Utah Health Sciences Center, Salt Lake City, Utah, USA.
Can J Cardiol. 2013 Oct;29(10):1194-202. doi: 10.1016/j.cjca.2013.07.679.
Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical practice today. Until recently, the therapeutic approaches for AF have been limited by imperfect risk prediction models and suboptimal approaches for AF ablation. Magnetic resonance imaging (MRI) for the detection of left atrial (LA) fibrosis and correlation of these structural remodelling changes to outcomes of stroke, AF recurrence, and congestive heart failure have provided us with information to optimize the care of our patients with AF based on screening for fibrotic atrial cardiomyopathy, for which AF is the arrhythmic manifestation. These data allow us to bring these new imaging modalities to the forefront of AF management and the delivery of personalized medicine. Future developments promise to improve the outcomes and safety for AF and fibrotic atrial cardiomyopathy.
心房颤动(AF)是当今临床实践中最常见的心律失常。直到最近,AF 的治疗方法还受到不完善的风险预测模型和 AF 消融的不理想方法的限制。磁共振成像(MRI)用于检测左心房(LA)纤维化,并将这些结构重塑变化与中风、AF 复发和充血性心力衰竭的结果相关联,为我们提供了信息,可根据筛查纤维性心房心肌病优化 AF 患者的护理,AF 是心律失常的表现。这些数据使我们能够将这些新的成像方式应用于 AF 管理和个性化医疗的前沿。未来的发展有望改善 AF 和纤维性心房心肌病的结果和安全性。